FKBP5

Chr 6

FKBP prolyl isomerase 5

Also known as: AIG6, FKBP51, FKBP54, P54, PPIase, Ptg-10

The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. This encoded protein is a cis-trans prolyl isomerase that binds to the immunosuppressants FK506 and rapamycin. It is thought to mediate calcineurin inhibition. It also interacts functionally with mature hetero-oligomeric progesterone receptor complexes along with the 90 kDa heat shock protein and P23 protein. This gene has been found to have multiple polyadenylation sites. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]

55
ClinVar variants
7
Pathogenic / LP
0.73
pLI score
8
Active trials
Clinical SummaryFKBP5
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.73) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
7 Pathogenic / Likely Pathogenic· 43 VUS of 55 total submissions
💊
Clinical Trials
8 active or recruiting trials — potential therapeutic options may be available
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.42LOEUF
pLI 0.734
Z-score 3.54
OE 0.18 (0.090.42)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
1.62Z-score
OE missense 0.71 (0.630.81)
179 obs / 251.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.18 (0.090.42)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.71 (0.630.81)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.91
01.21.6
LoF obs/exp: 4 / 21.9Missense obs/exp: 179 / 251.1Syn Z: 0.71

ClinVar Variant Classifications

55 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic1
VUS43
Likely Benign2
Benign3
6
Pathogenic
1
Likely Pathogenic
43
VUS
2
Likely Benign
3
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
6
0
6
Likely Pathogenic
0
0
1
0
1
VUS
0
40
3
0
43
Likely Benign
0
2
0
0
2
Benign
0
0
2
1
3
Total04212155

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

FKBP5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype

No OMIM entries found.

📖
GeneReview available — FKBP5
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Pharmacogenomics of suicidal events.
Brent D et al.·Pharmacogenomics
2010Review
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Healthy

Effect of Transcranial Alternative Current Stimulation at Alpha Frequency (α-tACS) on Stressed Healthy Subjects

RECRUITING
NCT06229002Phase NAHôpital le VinatierStarted 2024-01-24
Transcranial alternative current stimulation (tACS) at alpha frequencySham stimulation
Cortisol ExcessStress, PsychologicalAnxiety

Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá

ACTIVE NOT RECRUITING
NCT05315388Phase NAJeadran N. Malagón-RojasStarted 2022-10-15
Immersion therapy in nature - Vitamin N
Congenital Adrenal Hyperplasia (CAH)

Fertility And Sexual Function In CAH: CALLIOPE

RECRUITING
NCT07099456University of Roma La SapienzaStarted 2024-11-01
Major Depressive DisorderPostpartum Depression

Maternal Mental Health Trial

RECRUITING
NCT04685148Phase PHASE1, PHASE2Vibe G Frøkjær, MD, PhDStarted 2021-02-03
Transdermal patch estradiolTransdermal patch placebo
Healthy Participants

Reality-monitoring & Stress

RECRUITING
NCT05595434Phase NAHôpital le VinatierStarted 2024-04-25
Acute Maastricht Stress Test (MAST), active condition.Acute Maastricht Stress Test (MAST), placebo condition
Maternal DistressChild Development

In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics

RECRUITING
NCT07296107Columbia UniversityStarted 2026-05
Prenatal maternal psychosocial and biological assessment protocol
Paraphilic DisordersSexual AddictionParasomnia

Paraphilic Disorders and Other Conditions With Risk for Sexual Violence: a Case-control Study

RECRUITING
NCT05861752Region StockholmStarted 2022-10-19
Treatment as usual
Posttraumatic Stress Disorder

Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry

RECRUITING
NCT04529031Phase NAUniversity of California, Los AngelesStarted 2024-09-01
Reminder Focused Positive Psychiatryattentional control condition (group process)